Tag: GCP compliance

Monitoring and Source Verification in Decentralized Trial Models

November 16, 2025November 15, 2025 digi

Monitoring and Source Verification in Decentralized Trial Models In recent years, the landscape of clinical research has undergone a transformative shift, particularly with the rise of decentralized trial models. The adaptation of digital technologies in clinical trials offers promising benefits and efficiency gains. However, implementing effective monitoring and source verification practices within decentralized models presents…

GCP in Digital/Decentralized Settings

Participant Safety and Signal Detection in Highly Digital Studies

November 16, 2025November 15, 2025 digi

Participant Safety and Signal Detection in Highly Digital Studies Participant Safety and Signal Detection in Highly Digital Studies Introduction to Participant Safety in Digital Clinical Trials The rise of highly digital studies, including decentralized clinical trials (DCTs), has transformed the landscape of translational clinical research, demanding a fresh perspective on participant safety and signal detection….

GCP in Digital/Decentralized Settings

Using CAPA Data to Drive a Culture of Continuous Clinical Quality Improvement

November 16, 2025November 15, 2025 digi

Using CAPA Data to Drive a Culture of Continuous Clinical Quality Improvement Using CAPA Data to Drive a Culture of Continuous Clinical Quality Improvement In the ever-evolving landscape of clinical trials, ensuring quality and compliance is paramount. Corrective and Preventive Action (CAPA) processes serve as essential components in fostering a robust culture of continuous quality…

Corrective & Preventive Action (CAPA) Lifecycle

Managing Difficult Conversations With Overwhelmed or Underperforming Sites

November 16, 2025November 15, 2025 digi

Managing Difficult Conversations With Overwhelmed or Underperforming Sites Managing Difficult Conversations With Overwhelmed or Underperforming Sites In the context of pharma clinical trials, managing communication effectively is vital, especially when dealing with sites that may be facing overwhelming pressures or underperformance issues. This comprehensive guide aims to equip clinical operations and regulatory affairs professionals with…

Site Communications & Issue Escalation

Rapid Communication in Safety-Critical Situations and Urgent Amendments

November 16, 2025November 15, 2025 digi

Rapid Communication in Safety-Critical Situations and Urgent Amendments Effective communication is vital in clinical research, particularly during safety-critical situations and when urgent amendments are necessary. Good communication can streamline processes, mitigate risks, and ensure compliance with regulatory standards across different jurisdictions, such as the FDA in the US, EMA in the EU, and MHRA in…

Site Communications & Issue Escalation

Managing BYOD, Wearables and Sensor Data in Compliance With GCP

November 16, 2025November 15, 2025 digi

Managing BYOD, Wearables and Sensor Data in Compliance With GCP Managing BYOD, Wearables and Sensor Data in Compliance With GCP In the evolving landscape of clinical research, the integration of Bring Your Own Device (BYOD) strategies and wearable technologies presents unique opportunities and challenges in data management and compliance. This comprehensive guide is geared towards…

GCP in Digital/Decentralized Settings

Investigator Responsibilities When Care Is Delivered Remotely

November 16, 2025November 15, 2025 digi

Investigator Responsibilities When Care Is Delivered Remotely Investigator Responsibilities When Care Is Delivered Remotely The shift towards remote care in clinical trials has fundamentally transformed the way that healthcare is delivered to trial participants. As clinical operations, regulatory affairs, and medical affairs professionals in the US, UK, and EU navigate this landscape, it’s essential to…

GCP in Digital/Decentralized Settings

CAPA Boards and Governance Committees: Charters and Decision Rights

November 16, 2025November 15, 2025 digi

CAPA Boards and Governance Committees: Charters and Decision Rights The management of corrective and preventive actions (CAPA) within clinical research is paramount for ensuring compliance and maintaining the integrity of clinical trial systems. Governance committees play a crucial role in overseeing CAPA processes, making decisions that have far-reaching implications for clinical research projects. This tutorial…

Corrective & Preventive Action (CAPA) Lifecycle

Issue Escalation Pathways From Site to CRO to Sponsor

November 16, 2025November 15, 2025 digi

Issue Escalation Pathways From Site to CRO to Sponsor Issue Escalation Pathways From Site to CRO to Sponsor In today’s intricate landscape of clinical trials, particularly in the context of covid clinical trials, ensuring effective communication pathways for issue escalation is imperative. This tutorial serves as a comprehensive guide for clinical operations, regulatory affairs, and…

Site Communications & Issue Escalation

Documenting Communications in CTMS, eTMF and Site Files

November 16, 2025November 15, 2025 digi

Documenting Communications in CTMS, eTMF and Site Files Documenting Communications in CTMS, eTMF and Site Files Effective communication during clinical trials is critical to ensuring compliance and facilitating efficient operations. This guide outlines the steps necessary for documenting communications within Clinical Trial Management Systems (CTMS), electronic Trial Master Files (eTMF), and site files. We will…

Site Communications & Issue Escalation